Princeton Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-450
| Closed | -$43K | – | 95 |
|
|
2022
Q3 | $43K | Hold |
450
| – | – | 0.02% | 89 |
|
|
2022
Q2 | $88K | Sell |
450
-16
| -3% | -$3.13K | 0.03% | 94 |
|
|
2022
Q1 | $108K | Hold |
466
| – | – | 0.03% | 108 |
|
|
2021
Q4 | $184K | Sell |
466
-18
| -4% | -$7.11K | 0.05% | 111 |
|
|
2021
Q3 | $216K | Buy |
484
+19
| +4% | +$8.48K | 0.07% | 104 |
|
|
2021
Q2 | $181K | Buy |
465
+24
| +5% | +$9.34K | 0.06% | 105 |
|
|
2021
Q1 | $158K | Hold |
441
| – | – | 0.05% | 100 |
|
|
2020
Q4 | $216K | Sell |
441
-102
| -19% | -$50K | 0.08% | 98 |
|
|
2020
Q3 | $176K | Hold |
543
| – | – | 0.07% | 92 |
|
|
2020
Q2 | $198K | Buy |
+543
| New | +$198K | 0.09% | 91 |
|
|
2019
Q4 | – | Sell |
-181
| Closed | -$64K | – | 103 |
|
|
2019
Q3 | $64K | Buy |
181
+88
| +95% | +$31.1K | 0.03% | 139 |
|
|
2019
Q2 | $47K | Buy |
+93
| New | +$47K | 0.02% | 154 |
|